Blog
USDTL Now GSA Certified Contractor
DES PLAINES, Ill. (May 25, 2012) – Des Plaines, IL,—We are pleased to announce that United States Drug Testing Laboratories, Inc. (USDTL) has been awarded a 5-year Federal Supply Schedule (FSS) contract (V797P-2097D) from the Department of Veteran Affairs as part of the General Services Administration (GSA) Multiple Award Schedule which went into effect February 15, 2012. USDTL received the award for Schedule 621II Medical Laboratory Testing and Analytical Services as a certified small business enterprise.
VA Centers around the nation can now utilize USDTL’s state-of-the-art, long-term alcohol and drug biomarkers to assist with the treatment of chronic substance abuse. The contract also allows OB/GYN practitioners at all US military hospitals access to USDTL’s state-of-the-art toxicology services for newborn meconium and umbilical cord tissue testing for prenatal exposure to substances of abuse and heavy alcohol use.
USDTL is a leader in the toxicology industry; bringing new and innovative services to market to assist healthcare professionals to solve complex addiction issues. Government purchasers may contact Client Services at (800) 235-2367 or clientservice@usdtl.com to obtain more information and to coordinate specimen collection instructions and supplies.
Contact:
Joseph Jones, Vice President of Laboratory Services
joe.jones@usdtl.com
(800) 235-2367
- Drug Classes and Neurotransmitters: Amphetamine, Cocaine, and Hallucinogens
- Environmental Exposure Testing for Delta-8 THC, Delta-9 THC, Delta-10 THC, and CBD
- Bromazolam and Synthetic Benzodiazepines
- Winter Weather Delay Update
- Tianeptine
- Revolutionizing DUI Interventions: Wisconsin’s Breakthrough in Biomarker Testing for Impaired Drivers
- 3 FAQs You Should Know About Newborn Drug Testing
- The Brain Chemistry Behind Tolerance and Withdrawal
- March 2024 (1)
- February 2024 (1)
- January 2024 (3)
- December 2023 (1)
- November 2023 (1)
- August 2023 (1)